<p><strong>Pediatric Use</strong>:&nbsp;The safety and effectiveness of Nedocromil inhalation aerosol in patients below the age of 6 years have not been established.<br />
<br />
<strong>Geriatric Use</strong>:&nbsp;Clinical studies of Nedocromil inhalation aerosol did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</p>